Alterity Therapeutics Files 6-K Report
Ticker: ATHE · Form: 6-K · Filed: Apr 29, 2026 · CIK: 0001131343
| Field | Detail |
|---|---|
| Company | Alterity Therapeutics Ltd (ATHE) |
| Form Type | 6-K |
| Filed Date | Apr 29, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: foreign-issuer, regulatory-filing, sec-filing
TL;DR
Alterity Therapeutics filed a 6-K on 4/29/26, check EX-99.1 for details.
AI Summary
Alterity Therapeutics Ltd. filed a Form 6-K on April 29, 2026, reporting for the period ending April 30, 2026. The filing includes various documents, such as the 6-K form itself and exhibits like 'EX-99.1' and several graphic files. The company's business address is Level 3, 460 Bourke Street, Melbourne, Australia.
Why It Matters
This filing provides an update on Alterity Therapeutics' regulatory reporting status, which is important for investors tracking the company's compliance and disclosures.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign issuer and does not contain significant new financial or operational information that would inherently increase risk.
Key Players & Entities
- Alterity Therapeutics Ltd. (company) — Filer of the 6-K report
- 0001131343 (company) — CIK number for Alterity Therapeutics Ltd.
- 2026-04-29 (date) — Filing date of the 6-K report
- 2026-04-30 (date) — Period of report for the 6-K
- Level 3, 460 Bourke Street, Melbourne, Australia (location) — Business and mailing address of Alterity Therapeutics Ltd.
FAQ
What is the primary purpose of a Form 6-K filing?
A Form 6-K is a report of foreign issuer required by the SEC, used to furnish information that the company has made or is required to make public pursuant to the laws of its home country.
What is the CIK number for Alterity Therapeutics Ltd. as listed in the filing?
The CIK number for Alterity Therapeutics Ltd. is 0001131343.
When was this specific Form 6-K filed with the SEC?
This Form 6-K was filed with the SEC on April 29, 2026.
What is the period of report indicated for this filing?
The period of report for this filing is April 30, 2026.
Where is Alterity Therapeutics Ltd. located based on the filing?
Alterity Therapeutics Ltd.'s business and mailing address is Level 3, 460 Bourke Street, Melbourne, Australia.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 29, 2026 regarding ALTERITY THERAPEUTICS LTD (ATHE).